Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
12/31/1997 | WO1997049653A2 Solid phase tyrphostin library linked to matrices with memories |
12/31/1997 | CA2258936A1 Method for producing hybridisation complexes whose stability is substantially independent of the base composition of two hybridised nucleic acid molecules |
12/30/1997 | US5703223 Solid phase synthesis of oligonucleotides with stereospecific substituted phosphonate linkages by pentavalent grignard coupling |
12/30/1997 | US5703218 Useful in biosynthesis |
12/30/1997 | US5703054 Oligonucleotide modulation of protein kinase C |
12/30/1997 | US5703044 Plant protein |
12/30/1997 | US5703039 Chimeric toxins |
12/30/1997 | US5702946 Interleukins |
12/30/1997 | US5702936 Polypeptides |
12/30/1997 | US5702933 Control of fruit ripening and senescence in plants |
12/30/1997 | US5702926 Useful in strand displacement amplification |
12/30/1997 | US5702920 Polypeptides |
12/30/1997 | US5702903 Detecting gene that has been amplified or detecting increased expression of gene products |
12/30/1997 | US5702893 Hydrophobic nucleic acid probe |
12/30/1997 | US5702890 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
12/30/1997 | US5702888 Contacting nucleic acid with complementary nucleic acid probe having steroid hapten bound thereto by bridging group to hybridize, contacting with labelled antibody which binds to hapten, detecting labelled antibody |
12/29/1997 | EP0814164A2 A novel cDNA of direct-acting fibrinolytic serine protease |
12/29/1997 | EP0814160A2 KEX2 proteinase inhibitor |
12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |
12/29/1997 | EP0813610A1 Sequence-specific detection of nucleic acids |
12/29/1997 | EP0813609A1 Method of nucleic acid analysis |
12/29/1997 | EP0813539A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
12/29/1997 | EP0813419A1 Modulators of regulatory proteins |
12/29/1997 | EP0705270B1 Chemically modified oligonucleotide for site-directed mutagenesis |
12/24/1997 | WO1997048794A1 Amidase |
12/24/1997 | WO1997048721A1 Hodgkin's disease associated molecules and uses thereof |
12/24/1997 | WO1997048720A1 Nucleic acid molecule for enhancing gene expression |
12/24/1997 | WO1997048716A1 Method and kits for preparing multicomponent nucleic acid constructs |
12/24/1997 | WO1997048714A1 Chimeric mutational vectors having non-natural nucleotides |
12/24/1997 | CN1168676A Materials for the production of nanometer structures and use thereof |
12/24/1997 | CN1036783C Production Technology for extracting nuclear acid from natural plant cells |
12/24/1997 | CA2258573A1 Hodgkin's disease associated molecules and uses thereof |
12/24/1997 | CA2258570A1 Method and kits for preparing multicomponent nucleic acid constructs |
12/24/1997 | CA2258090A1 Chimeric mutational vectors having non-natural nucleotides |
12/23/1997 | US5700922 PNA-DNA-PNA chimeric macromolecules |
12/23/1997 | US5700921 Reacting nucleic acid with protected pro-thiol aryl azide, deprotecting, reacting with label conjugated to thiol-reactive group |
12/23/1997 | US5700919 Modified phosphoramidite process for the production of modified nucleic acids |
12/23/1997 | US5700911 Bone morphogenetic protein -11 (BMP-11) compositions |
12/23/1997 | US5700909 For stimulating neural cell outgrowth |
12/23/1997 | US5700785 Administering to treat retroviral infections |
12/23/1997 | US5700680 Fusion proteins |
12/23/1997 | US5700674 Culture product; replacing an amino acid sequence around a specific acid in wild type uricase by specific sequence by mutation |
12/23/1997 | US5700665 Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine |
12/23/1997 | US5700664 For pharmaceutical preparations for stimulating cells involved in immune response and proper functioning of hematopoietioc system |
12/23/1997 | US5700663 Modified at one or more potential glycosylation sites or at the arginine 393 position |
12/23/1997 | US5700643 Stable DNA constructs |
12/23/1997 | US5700636 Methods for selectively detecting microorganisms associated with vaginal infections in complex biological samples |
12/23/1997 | US5700470 Genetic engineered genome comprising a foreign gene and a promoter for gene expressing the foreign gene |
12/23/1997 | CA1339596C Viral expression inhibitors |
12/19/1997 | CA2208202A1 Novel proteinase inhibitor and gene encoding the inhibitor |
12/18/1997 | WO1997047754A1 Transcriptional silencing elements and their binding factors |
12/18/1997 | WO1997047639A1 Photocleavable cyclic oligonucleotide |
12/18/1997 | WO1997047637A1 Phosphotriester oligonucleotides, amidites and method of preparation |
12/18/1997 | WO1997047636A2 Intermediates for oligonucleotide synthesis |
12/18/1997 | WO1997047326A1 INHIBITION OF Ii SYNTHESIS |
12/18/1997 | WO1997047172A1 Vitamin d receptor isoform protein |
12/18/1997 | CA2257453A1 Intermediates for oligonucleotide synthesis |
12/17/1997 | EP0812921A2 Amplification and detection of chlamydia trachomatis nucleic acids |
12/17/1997 | EP0812916A2 Cathepsin k gene |
12/17/1997 | EP0812912A1 RNA Catalyst for cleaving specific RNA sequences |
12/17/1997 | EP0812911A2 A method of forming a macromolecular microgene polymer |
12/17/1997 | EP0812823A1 Chemiluminescent group-containing carbodiimide compound |
12/17/1997 | EP0726905A4 Single nucleotide polymorphisms and their use in genetic analysis |
12/17/1997 | EP0713494A4 Method of nucleic acid sequence selection |
12/17/1997 | EP0694079A4 Enzymatic ligation of 3'-amino-substituted olignucleotides |
12/17/1997 | EP0408675B1 Detection of human tumor progression and drug resistance |
12/17/1997 | CN1168156A Staphylokinase derivs. |
12/16/1997 | US5698687 Rna molecule containing modified nucloside |
12/16/1997 | US5698685 Morpholino-subunit combinatorial library and method |
12/16/1997 | US5698517 Thyroxin-binding HSA fragments |
12/16/1997 | US5698439 Novel malignant cell type markers of the interior nuclear matrix |
12/16/1997 | US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies |
12/16/1997 | US5698399 Isolation genomic dna; determination allelic pattern |
12/11/1997 | WO1997046670A1 Programmed sequential mutagenesis |
12/11/1997 | WO1997046597A1 Polymeric reagents for immobilizing biopolymers |
12/11/1997 | WO1997046571A1 Phosphorothioate oligonucleotides that bind to the v3-loop and uses thereof |
12/11/1997 | WO1997046570A1 Oligoribonucleotides and ribonucleases for cleaving rna |
12/11/1997 | WO1997046569A2 2'-substituted nucleosides and oligonucleotide derivatives |
12/11/1997 | WO1997046568A1 Nucleic acid mediated electron transfer |
12/11/1997 | WO1997046313A1 Immobilised linear oligonucleotide arrays |
12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy |
12/11/1997 | WO1997046100A1 Serpin enzyme complex receptor-mediated gene transfer |
12/11/1997 | CA2257534A1 Nucleic acid mediated electron transfer |
12/11/1997 | CA2256765A1 2'-substituted nucleosides and oligonucleotide derivatives |
12/11/1997 | CA2256558A1 Serpin enzyme complex receptor-mediated gene transfer |
12/10/1997 | EP0811682A2 Method of producing L-lysine |
12/10/1997 | EP0811385A2 Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease |
12/10/1997 | EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF |
12/10/1997 | EP0811067A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
12/10/1997 | EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
12/10/1997 | EP0811011A1 Carbohydrate conjugated bio-active compounds |
12/10/1997 | EP0810878A2 Rna photocleavage using texaphyrins |
12/10/1997 | CN1167505A Tie-2 ligands, methods of making and uses thereof |
12/10/1997 | CN1167155A Method for cleaving chimeric protein using processing enzyme |
12/09/1997 | US5696253 Polynucleoside chain with 3'→5' guanidyl linkages |
12/09/1997 | US5696251 Oligonucleotides |
12/09/1997 | US5696249 Nucleic acid ligands |
12/09/1997 | US5696248 Gene expression inhibitor, as probes for detecting nucleic acids, as viricides treating viral disease caused by htlv, influenza, hepatitis virus, papilloma virus |
12/09/1997 | US5696091 Use of growth factor and antimetabolite combination to prevent or retard secondary cataract formation |
12/09/1997 | US5696001 Fluorogenic compounds and their use |